NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Coupang, Inc. (NYSE: CPNG) resulting from allegations that Coupang may have issued materially misleading business information to the investing public. So What: If you purchased Coupang securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Ros. ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Klarna Group plc due to allegations of materially misleading business information issued by Klarna to the investing public [1] Group 1 - The investigation is focused on the potential impact of misleading information on Klarna's securities [1] - Shareholders who purchased Klarna securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Gauzy Ltd. (NASDAQ: GAUZ) resulting from allegations that Gauzy may have issued materially misleading business information to the investing public. So What: If you purchased Gauzy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen La. ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Western Alliance Bancorporation due to allegations of materially misleading business information [2][3] Group 1: Legal Action and Stock Impact - Western Alliance Bancorporation initiated a lawsuit against Cantor Group V LLC for fraud related to collateral loans, resulting in a 10.88% stock price drop on October 16, 2025 [4] Group 2: Class Action Details - Investors who purchased Western Alliance Bancorporation securities may be entitled to compensation through a class action without any out-of-pocket fees, facilitated by a contingency fee arrangement [3] - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [5] - The firm has been consistently ranked among the top firms for securities class action settlements since 2013 [5]

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [4]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [5]. - The company increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [5]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [5]. Legal Context - The investigation is being led by Bleichmar Fonti & Auld LLP, a law firm specializing in securities class actions [2][7]. - Investors are encouraged to seek legal options and submit their information to the firm, which operates on a contingency fee basis [6].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws following a significant drop in its stock price, which fell over 33% after the company reported disappointing Q3 2025 financial results [1][3][4]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue due to "hindsight evaluations of historical collection trends" [4]. - The company also increased its professional liability reserves by $54 million, citing "adverse prior period claim developments" related to claims from 2019 to 2022 and broader industry trends [4]. Stock Market Reaction - Following the financial disclosures on November 12, 2025, Ardent's stock price plummeted over 33% during trading on November 13, 2025 [4]. Legal Implications - Bleichmar Fonti & Auld LLP has initiated an investigation into Ardent Health, encouraging investors to seek additional information regarding potential legal options [1][5].

Core Viewpoint - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [3]. Financial Performance - On November 12, 2025, Ardent reported a $43 million decrease in revenue for Q3 2025 after conducting evaluations of historical collection trends [4]. - The company also increased its professional liability reserves by $54 million due to adverse claim developments from 2019 to 2022 and broader industry trends [4]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [4]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages investors to seek additional information regarding their legal options [2][5]. - The law firm has a strong track record in securities class actions, having recovered significant amounts for shareholders in previous cases [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Tvardi Therapeutics, Inc. due to allegations of materially misleading business information issued to the investing public [1] Company Summary - Tvardi Therapeutics, Inc. (NASDAQ: TRVD) is facing scrutiny regarding the accuracy of its business communications to investors [1] - Shareholders who purchased Tvardi Therapeutics securities may be entitled to compensation without incurring out-of-pocket fees or costs [1]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Informatica Inc. due to allegations of materially misleading business information issued by the company [1] Group 1 - The investigation is focused on potential securities claims related to Informatica Inc. (NYSE: INFA) [1] - Shareholders who purchased Informatica securities may be entitled to compensation [1] - Compensation may be available without any out-of-pocket fees or costs through a contingency fee arrangement [1]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Trinseo PLC due to allegations of materially misleading business information issued by the company [1] Group 1 - The investigation is focused on Trinseo PLC (NYSE: TSE) and its potential misrepresentation of business information to investors [1] - Shareholders who purchased Trinseo securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]